Abstract
Introduction
Serum phenotyping of elite cyclists regarding cortisol, IGF1 and testosterone is a way to detect endocrine disruptions possibly explained by exercise overload, non-balanced diet or by doping. This latter disruption-driven approach is supported by fundamental physiology although without any evidence of any metabolic markers.
Objectives
Serum samples were distributed through Low, High or Normal endocrine classes according to hormone concentration. A 1H NMR metabolomic study of 655 serum obtained in the context of the longitudinal medical follow-up of 253 subjects was performed to discriminate the three classes for every endocrine phenotype.
Methods
An original processing algorithm was built which combined a partial-least squares-based orthogonal correction of metabolomic signals and a shrinkage discriminant analysis (SDA) to get satisfying classifications. An extended validation procedure was used to plan in larger size cohorts a minimal size to get a global prediction rate (GPR), i.e. the product of the three class prediction rates, higher than 99.9%.
Results
Considering the 200 most SDA-informative variables, a sigmoidal fitting of the GPR gave estimates of a minimal sample size to 929, 2346 and 1408 for cortisol, IGF1 and testosterone, respectively. Analysis of outliers from cortisol and testosterone Normal classes outside the 97.5%-confidence limit of score prediction revealed possibly (i) an inadequate protein intake for outliers or (ii) an intake of dietary ergogenics, glycine or glutamine, which might explain the significant presence of heterogeneous metabolic profiles in a supposedly normal cyclists subgroup.
Conclusion
In a next validation metabolomics study of a so-sized cohort, anthropological, clinical and dietary metadata should be recorded in priority at the blood collection time to confirm these functional hypotheses.
Similar content being viewed by others
Data availability
Data available at www.ebi.ac.uk/metabolights/MTBLS2799.
Abbreviations
- AAS:
-
Androgenic anabolic steroids
- ABP:
-
Athletics Biological Passport
- AFLD:
-
Agence Française de Lutte contre le Dopage— French Anti-doping Agency
- ANOVA:
-
ANalysis Of VAriance
- BATMAN:
-
Bayesian AuTomated Metabolite Analyser for NMR spectra
- cat scores:
-
Correlation-adjusted t-scores
- CPMG:
-
Carr–Purcell–Meiboom–Gill NMR sequence
- E:
-
Epitestosterone
- FFC:
-
French Federation of Cycling
- GH:
-
Growth hormone
- GPR:
-
Global prediction rate
- IC:
-
Independent component
- ICDA:
-
Independent Component—Discriminant Analysis
- IGF1:
-
Insulin-like growth factor 1
- LS:
-
Learning size (number of samples selected in the dataset)
- MAGIC:
-
Markov Affinity-based Graph Imputation of Cells
- MANOVA:
-
Multivariate ANalysis Of VAriance
- MDS:
-
MultiDimensional Scaling
- NV:
-
Number of selected ordered variables
- nls:
-
Non-linear squares fitting
- OSC:
-
Orthogonal signal correction
- PCA:
-
Principal component analysis
- PHATE:
-
Mapping using potential of heat-diffusion affinity-based transition embedding
- PLS-DA:
-
Partial least squares-discriminant analysis
- PLSR:
-
Partial least squares regression
- PR:
-
Prediction rate
- SDA:
-
Shrinkage discriminant analysis
- T:
-
Testosterone
- UCI:
-
Union Cycliste Internationale—International Cycling Union
- WADA:
-
Word Anti Doping Agency
References
Ahdesmäki, M., & Strimmer, K. (2010). Feature selection in omics prediction problems using cat scores and false non-discovery rate control. Annals of Applied Statistics, 4, 503–519. https://doi.org/10.1214/09-AOAS277
Alladio, E., Caruso, R., Gerace, E., Amante, E., Salomone, A., & Vincenti, M. (2016). Application of multivariate statistics to the Steroidal Module of the Athlete Biological Passport: A proof of concept study. Analytica Chimica Acta, 922, 19–29. https://doi.org/10.1016/j.aca.2016.03.051
Alves, A., Bassot, A., Bulteau, A. L., Pirola, L., & Morio, B. (2019). Glycine metabolism and its alterations in obesity and metabolic diseases. Nutrients, 11(6), 1356. https://doi.org/10.3390/nu11061356
Amante, E., Pruner, S., Alladio, E., Salomone, A., Vincenti, M., & Bro, R. (2019). Multivariate interpretation of the urinary steroid profile and training-induced modifications. The case study of a Marathon runner. Drug Testing and Analysis, 11, 1556–1565. https://doi.org/10.1002/dta.2676
Ayotte, C., Miller, J., & Thevis, M. (2017). Challenges in modern anti-doping analytical science. Medicine & Sport Science, 62, 68–76. https://doi.org/10.1159/000460701
Barker, M. L., & Rayens, W. (2003). Partial least squares for discrimination. Journal of Chemometrics, 17, 166–173. https://doi.org/10.1002/cem.785
Bellar, D., LeBlanc, N. R., & Campbell, B. (2015). The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength. Journal of International Society Sports Nutrition, 12, 42. https://doi.org/10.1186/s12970-015-0103-x
Broersen, L. H., Pereira, A. M., Jørgensen, J. O., & Dekkers, O. M. (2015). Adrenal insufficiency in corticosteroids use: Systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism, 100, 2171–2180. https://doi.org/10.1210/jc.2015-1218
Buford, B. N., & Koch, A. J. (2004). Glycine-arginine-alpha-ketoisocaproic acid improves performance of repeated cycling sprints. Medicine & Science in Sports & Exercise, 36, 583–587.
Cadegiani, F. A., Kater, C. E., & Gazola, M. (2019). Clinical and biochemical characteristics of high-intensity functional training (HIFT) and overtraining syndrome: Findings from the EROS study (The EROS-HIFT). Journal of Sports Sciences, 37(11), 1296–1307. https://doi.org/10.1080/02640414.2018.1555912
Carrillo, J. A., & Benítez, J. (1994). Caffeine metabolism in a healthy Spanish population: N-acetylator phenotype and oxidation pathways. Clinical Pharmacology & Therapeutics, 55(3), 293–304. https://doi.org/10.1038/clpt.1994.30
Carrillo, J. A., & Benitez, J. (1996). CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine. British Journal of Clinical Pharmacology, 41(6), 605–608. https://doi.org/10.1046/j.1365-2125.1996.35418.x
Colberg, S. R., Sigal, R. J., Yardley, J. E., Riddell, M. C., Dunstan, D. W., Dempsey, P. C., et al. (2016). Physical activity/exercise and diabetes: A position statement of the American diabetes association. Diabetes Care, 39, 2065–2079. https://doi.org/10.2337/dc16-1728
Conlay, L. A., Sabounjian, L. A., & Wurtman, R. J. (1992). Exercise and neuromodulators: Choline and acetylcholine in marathon runners. International Journal of Sports Medicine, 13(Suppl 1), S141-142. https://doi.org/10.1055/s-2007-1024619
Costill, D. L., Dalsky, G. P., & Fink, W. J. (1978). Effects of caffeine ingestion on metabolism and exercise performance. Medicine and Science in Sports, 10(3), 155–158.
Cottret, L., Frainay, C., Chazalviel, M., Cabanettes, F., Gloaguen, Y., Camenen, E., Merlet, B., Heux, S., Portais, J. C., Poupin, N., Vinson, F., & Jourdan, F. (2018). MetExplore: Collaborative edition and exploration of metabolic networks. Nucleic Acids Research, 46(W1), W495–W502. https://doi.org/10.1093/nar/gky301
de Hon, O., & van Bottenburg, M. (2017). True dopers or negligent athletes? An analysis of anti-doping rule violations reported to the world anti-doping agency 2010–2012. Substance Use & Misuse, 52(14), 1932–1936. https://doi.org/10.1080/10826084.2017.1322105
Díaz-Flores, M., Cruz, M., Duran-Reyes, G., Munguia-Miranda, C., Loza-Rodríguez, H., Pulido-Casas, E., et al. (2013). Oral supplementation with glycine reduces oxidative stress in patients with metabolic syndrome, improving their systolic blood pressure. Canadian Journal of Physiology and Pharmacology, 91(10), 855–860. https://doi.org/10.1139/cjpp-2012-0341
Duclos, M., Guinot, M., Colsy, M., Merle, F., Baudot, C., Corcuff, J. B., & Lebouc, Y. (2007). High risk of adrenal insufficiency after a single articular steroid injection in athletes. Medicine & Science in Sports & Exercise, 39(7), 1036–1043. https://doi.org/10.1249/mss.0b013e31805468d6
Dumas, M. E., Canlet, C., André, F., Vercauteren, J., & Paris, A. (2002a). Metabonomic assessment of physiological disruptions using 1H–13C HMBC-NMR spectroscopy combined with pattern recognition procedures performed on filtered variables. Analytical Chemistry, 74, 2261–2273. https://doi.org/10.1021/ac0156870
Dumas, M. E., Canlet, C., Vercauteren, J., André, F., & Paris, A. (2005). Homeostatic signature of anabolic steroids in cattle using 1H–13C HMBC NMR metabonomics. Journal of Proteome Research, 4, 1493–1502. https://doi.org/10.1021/pr0500556
Dumas, M. E., Debrauwer, L., Beyet, L., Lesage, D., André, F., Paris, A., & Tabet, J. C. (2002b). Analyzing the physiological signature of anabolic steroids in cattle urine using pyrolysis/metastable atom bombardment mass spectrometry and pattern recognition. Analytical Chemistry, 74, 5393–5404. https://doi.org/10.1021/ac025656k
Earnest, C. P., & Rasmussen, C. (2015). Nutritional supplements for endurance athletes. In M. Greenwood, M. B. Cooke, T. Ziegenfuss, D. S. Kalman, & J. Antonio (Eds.), Nutritional supplements in sports and exercise (pp. 253–272). Springer International Publishing. https://doi.org/10.1007/978-3-319-18230-8_11
Erickson, M. A., Schwarzkopf, R. J., & McKenzie, R. D. (1987). Effects of caffeine, fructose, and glucose ingestion on muscle glycogen utilization during exercise. Medicine & Science in Sports & Exercise, 19(6), 579–583.
Fabregat, A., Marcos, J., Segura, J., Ventura, R., & Pozo, O. J. (2016). Factors affecting urinary excretion of testosterone metabolites conjugated with cysteine. Drug Testing Analysis, 8(1), 110–119. https://doi.org/10.1002/dta.1801
Gao, X., Wang, Y., & Sun, G. (2017). High dietary choline and betaine intake is associated with low insulin resistance in the Newfoundland population. Nutrition, 33, 28–34. https://doi.org/10.1016/j.nut.2016.08.005
Guinot, M., Duclos, M., Idres, N., Souberbielle, J.-C., Megret, A., & Le Bouc, Y. (2007). Value of basal serum cortisol to detect corticosteroid-induced adrenal insufficiency in elite cyclists. European Journal of Applied Physiology, 99, 205–216. https://doi.org/10.1007/s00421-006-0332-4
Habchi, B., Alves, S., Jouan-Rimbaud Bouveresse, D., Moslah, B., Paris, A., Lécluse, Y., Gauduchon, P., Lebailly, P., Rutledge, D. N., & Rathahao-Paris, E. (2017). An innovative chemometric method for processing direct introduction high resolution mass spectrometry metabolomic data: Independent component–discriminant analysis (IC–DA). Metabolomics, 13, 45. https://doi.org/10.1007/s11306-017-1179-x
Hao, J., Liebeke, M., Astle, W., De Lorio, M., Bundy, J. G., & Ebbels, T. M. (2014). Bayesian deconvolution and quantification of metabolites in complex 1D NMR spectra using BATMAN. Nature Protocol, 9, 1416–1427. https://doi.org/10.1038/nprot.2014.090
Holt, R. I., Erotokritou-Mulligan, I., McHugh, C., Bassett, E. E., Bartlett, C., Fityan, A., Bacon, J. L., Cowan, D. A., & Sönksen, P. H. (2010). The GH-2004 project: The response of IGF1 and type III pro-collagen to the administration of exogenous GH in non-Caucasian amateur athletes. European Journal of Endocrinology, 163(1), 45–54. https://doi.org/10.1530/EJE-09-0978
Holt, R. I., & Sönksen, P. H. (2008). Growth hormone, IGF-I and insulin and their abuse in sport. British Journal of Pharmacology, 154(3), 542–556. https://doi.org/10.1038/bjp.2008.99
Howe, C. C. F., Alshehri, A., Muggeridge, D., Mullen, A. B., Boyd, M., Spendiff, O., Moir, H. J., & Watson, D. G. (2018). Untargeted metabolomics profiling of an 80.5 km simulated treadmill ultramarathon. Metabolites, 8, 14. https://doi.org/10.3390/metabo8010014
Iljukov, S., & Schumacher, Y. O. (2017). Performance profiling-perspectives for anti-doping and beyond. Frontiers in Physiology, 8, 1102. https://doi.org/10.3389/fphys.2017.01102
Jacobs, P. L., Goldstein, E. R., Blackburn, W., Orem, I., & Hughes, J. J. (2009). Glycine propionyl-l-carnitine produces enhanced anaerobic work capacity with reduced lactate accumulation in resistance trained males. Journal International Society Sports Nutrition, 6, 9.
Jeanneret, F., Tonoli, D., Rossier, M. F., Saugy, M., Boccard, J., & Rudaz, S. (2016). Evaluation of steroidomics by liquid chromatography hyphenated to mass spectrometry as a powerful analytical strategy for measuring human steroid perturbations. Journal of Chromatography A, 1430, 97–112. https://doi.org/10.1016/j.chroma.2015.07.008
Kawamura, T., Okubo, T., Sato, K., Fujita, S., Goto, K., Hamaoka, T., & Iemitsu, M. (2012). Glycerophosphocholine enhances growth hormone secretion and fat oxidation in young adults. Nutrition, 28(11–12), 1122–1126. https://doi.org/10.1016/j.nut.2012.02.011
Kim, H. J., Choi, M. S., Rehman, S. U., Ji, Y. S., Yu, J. S., Nakamura, K., & Yoo, H. H. (2019). Determination of urinary caffeine metabolites as biomarkers for drug metabolic enzyme activities. Nutrients, 11(8), 1947. https://doi.org/10.3390/nu11081947
Kingsbury, K. J., Kay, L., & Hjelm, M. (1998). Contrasting plasma free amino acid patterns in elite athletes: Association with fatigue and infection. British Journal of Sports Medicine, 32(1), 25–32. https://doi.org/10.1136/bjsm.32.1.25
Lawler, N. G., Abbiss, C. R., Gummer, J. P. A., Broadhurst, D. I., Govus, A. D., Fairchild, T. J., Thompson, K. G., Garvican-Lewis, L. A., Gore, C. J., Maker, G. L., Trengove, R. D., & Peiffer, J. J. (2019). Characterizing the plasma metabolome during 14 days of live-high, train-low simulated altitude: A metabolomic approach. Experimental Physiology, 104, 81–92. https://doi.org/10.1113/EP087159
Lehtihet, M., Bhuiyan, H., Dalby, A., Ericsson, M., & Ekström, L. (2019). Longitudinally monitoring of P-III-NP, IGF-I, and GH-2000 score increases the probability of detecting two weeks’ administration of low-dose recombinant growth hormone compared to GH-2000 decision limit and GH isoform test and micro RNA markers. Drug Testing and Analysis, 11, 411–421. https://doi.org/10.1002/dta.2506
Marcus, L., Soileau, J., Judge, L. W., & Bellar, D. (2017). Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance. Journal of International Society Sports Nutrition, 14, 39. https://doi.org/10.1186/s12970-017-0196-5
Maughan, R. J., Burke, L. M., Dvorak, J., Larson-Meyer, D. E., Peeling, P., Phillips, S. M., Rawson, E. S., Walsh, N. P., Garthe, I., Geyer, H., Meeusen, R., van Loon, L. J. C., Shirreffs, S. M., Spriet, L. L., Stuart, M., Vernec, A., Currell, K., Ali, V. M., Budgett, R. G., … Engebretsen, L. (2018). IOC consensus statement: Dietary supplements and the high-performance athlete. British Journal of Sports Medicine, 52(7), 439–455. https://doi.org/10.1136/bjsports-2018-099027
McCarty, M. F., O’Keefe, J. H., & DiNicolantonio, J. J. (2018). Dietary glycine is rate-limiting for glutathione synthesis and may have broad potential for health protection. Ochsner Journal, 18, 81–87.
Montagna, S., & Hopker, J. (2018). A Bayesian approach for the use of athlete performance data within anti-doping. Frontiers in Physiology, 9, 884. https://doi.org/10.3389/fphys.2018.00884
Moon, K. R., van Dijk, D., Wang, Z., Gigante, S., Burkhardt, D. B., Chen, W. S., Yim, K., Elzen, A. V. D., Hirn, M. J., Coifman, R. R., Ivanova, N. B., Wolf, G., & Krishnaswamy, S. (2019). Visualizing structure and transitions in high-dimensional biological data. Nature Biotechnology, 37(12), 1482–1492. https://doi.org/10.1038/s41587-019-0336-3. Erratum in: Nature Biotechnology, 38(1), 108 (2020).
Nehlig, A. (2018). Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacological Reviews, 70, 384–411. https://doi.org/10.1124/pr.117.014407
Penry, J. T., & Manore, M. M. (2008). Choline: An important micronutrient for maximal endurance-exercise performance? International Journal of Sport Nutrition and Exercise Metabolism, 18, 191–203. https://doi.org/10.1123/ijsnem.18.2.191
Pitsiladis, Y. P., Durussel, J., & Rabin, O. (2014). An integrative “omics” solution to the detection of recombinant human erythropoietin and blood doping. British Journal of Sports Medicine, 48, 856–861. https://doi.org/10.1136/bjsports-2014-093529
Ponzetto, F., Boccard, J., Nicoli, R., Kuuranne, T., Saugy, M., & Rudaz, S. (2018). UHPLC-HRMS analysis for steroid profiling in serum (steroidomics). Methods in Molecular Biology (Clifton, N.J.), 1738, 261–278. https://doi.org/10.1007/978-1-4939-7643-0_18
Ponzetto, F., Boccard, J., Nicoli, R., Kuuranne, T., Saugy, M., & Rudaz, S. (2019). Steroidomics for highlighting novel serum biomarkers of testosterone doping. Bioanalysis, 11(12), 1171–1187. https://doi.org/10.4155/bio-2019-0079
Pozo, O. J., Marcos, J., Ventura, R., Fabregat, A., & Segura, J. (2010). Testosterone metabolism revisited: Discovery of new metabolites. Analytical Bioanalytical Chemistry, 398(4), 1759–1770. https://doi.org/10.1007/s00216-010-4082-0
R Core Team. (2019). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/
Raizel, R., Leite, J. S. M., Hypólito, T. M., Coqueiro, A. Y., Newsholme, P., Cruzat, V. F., & Tirapegui, J. (2016). Determination of the anti-inflammatory and cytoprotective effects of l-glutamine and l-alanine, or dipeptide, supplementation in rats submitted to resistance exercise. British Journal of Nutrition, 116, 470–479.
Reichel, C. (2011). OMICS-strategies and methods in the fight against doping. Forensic Science International, 213, 20–34. https://doi.org/10.1016/j.forsciint.2011.07.031
Robinson, N., Sottas, P. E., Mangin, P., & Saugy, M. (2007). Bayesian detection of abnormal hematological values to introduce a no-start rule for heterogeneous populations of athletes. Haematologica, 92(8), 1143–1144. https://doi.org/10.3324/haematol.11182
Robinson, N., Sottas, P. E., & Schumacher, Y. O. (2017). The athlete biological passport: How to personalize anti-doping testing across an athlete’s career? Medicine and Sport Science, 62, 107–118. https://doi.org/10.1159/000460722
Rohart, F., Gautier, B., Singh, A., & Lê Cao, K. A. (2017). mixOmics: An R package for ’omics feature selection and multiple data integration. PLoS Computational Biology, 13(11), e1005752. https://doi.org/10.1371/journal.pcbi.1005752
Rohart, F., Paris, A., Laurent, B., Canlet, C., Molina, J., Mercat, M. J., Tribout, T., Muller, N., Iannuccelli, N., Villa-Vialaneix, N., Liaubet, L., Milan, D., & San Cristobal, M. (2012). Phenotypic prediction based on metabolomic data for growing pigs from three main European breeds. Journal of Animal Science, 90, 4729–4740. https://doi.org/10.2527/jas.2012-5338
Rowbottom, D. G., Keast, D., & Morton, A. R. (1996). The emerging role of glutamine as an indicator of exercise stress and overtraining. Sports Medicine, 21(2), 80–97. https://doi.org/10.2165/00007256-199621020-00002
Samworth, R. J. (2012). Stein’s paradox. Eureka, 62, 38–41.
Schneiker, K. T., Bishop, D., Dawson, B., & Hackett, L. P. (2006). Effects of caffeine on prolonged intermittent-sprint ability in team-sport athletes. Medicine & Science in Sports & Exercise, 38(3), 578–585. https://doi.org/10.1249/01.mss.0000188449.18968.62
Schumacher, Y. O., & Pottgiesser, T. (2009). Performance profiling: A role for sport science in the fight against doping? International Journal Sports Physiology & Performance, 4(1), 129–133. https://doi.org/10.1123/ijspp.4.1.129
Shi, R., Zhang, J., Fang, B., Tian, X., Feng, Y., Cheng, Z., Fu, Z., Zhang, J., & Wu, J. (2020). Runners’ metabolomic changes following marathon. Nutrition & Metabolism, 17(19), 2020. https://doi.org/10.1186/s12986-020-00436-0.Erratum.In:Nutrition&Metabolism17:53
Sieckmann, T., Elmongy, H., Ericsson, M., Bhuiyan, H., Lehtihet, M., & Ekström, L. (2020). Longitudinal studies of putative growth hormone (GH) biomarkers and hematological and steroidal parameters in relation to 2 weeks administration of human recombinant GH. Drug Testing and Analysis, 12(6), 711–719. https://doi.org/10.1002/dta.2787
Sottas, P. E., Baume, N., Saudan, C., Schweizer, C., Kamber, M., & Saugy, M. (2007). Bayesian detection of abnormal values in longitudinal biomarkers with an application to T/E ratio. Biostatistics, 8(2), 285–296. https://doi.org/10.1093/biostatistics/kxl009
Sottas, P. E., Robinson, N., Giraud, S., Taroni, F., Kamber, M., Mangin, P., & Saugy, M. (2006). Statistical classification of abnormal blood profiles in athletes. The International Journal of Biostatistics, 2, 1–21. https://doi.org/10.2202/1557-4679.1011
Sottas, P. E., Robinson, N., Rabin, O., & Saugy, M. (2011). The athlete biological passport. Clinical Chemistry, 57(7), 969–976. https://doi.org/10.1373/clinchem.2011.162271
Sottas, P. E., Robinson, N., & Saugy, M. (2010a). The athlete’s biological passport and indirect markers of blood doping. Handbook Experimental Pharmacology, 195, 305–326. https://doi.org/10.1007/978-3-540-79088-4_14
Sottas, P. E., Saudan, C., Schweizer, C., Baume, N., Mangin, P., & Saugy, M. (2008). From population- to subject-based limits of T/E ratio to detect testosterone abuse in elite sports. Forensic Science International, 174(2–3), 166–172. https://doi.org/10.1016/j.forsciint.2007.04.001
Sottas, P. E., Saugy, M., & Saudan, C. (2010b). Endogenous steroid profiling in the athlete biological passport. Endocrinology and Metabolism Clinics of North America, 39(1), 59–73, viii–ix. https://doi.org/10.1016/j.ecl.2009.11.003
Sotton, B., Paris, A., Le Manach, S., Blond, A., Lacroix, G., Millot, A., Duval, C., Huet, H., Qiao, Q., Labrut, S., Chiappetta, G., Vinh, J., Catherine, A., & Marie, B. (2017). Metabolic changes in Medaka fish induced by cyanobacterial exposures in mesocosms: An integrative approach combining proteomic and metabolomic analyses. Scientific Reports, 7(4051), 2018. https://doi.org/10.1038/s41598-017-04423-z.Erratum.In:ScientificReports,8:4270
Spriet, L. L., MacLean, D. A., Dyck, D. J., Hultman, E., Cederblad, G., & Graham, T. E. (1992). Caffeine ingestion and muscle metabolism during prolonged exercise in humans. American Journal of Physiology, 262(6 Pt 1), E891-898. https://doi.org/10.1152/ajpendo.1992.262.6.E891
Thevis, M., Geyer, H., Mareck, U., Sigmund, G., Henke, J., Henke, L., & Schänzer, W. (2007). Detection of manipulation in doping control urine sample collection: A multidisciplinary approach to determine identical urine samples. Analytical Bioanalytical Chemistry, 388(7), 1539–1543. https://doi.org/10.1007/s00216-006-1112-z
Umpierre, D., Ribeiro, P. A., Kramer, C. K., Leitão, C. B., Zucatti, A. T., Azevedo, M. J., Gross, J. L., Ribeiro, J. P., & Schaan, B. D. (2011). Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: A systematic review and meta-analysis. JAMA, 305(17), 1790–1799. https://doi.org/10.1001/jama.2011.576
van Dijk, D., Sharma, R., Nainys, J., Yim, K., Kathail, P., Carr, A. J., Burdziak, C., Moon, K. R., Chaffer, C. L., Pattabiraman, D., Bierie, B., Mazutis, L., Wolf, G., Krishnaswamy, S., & Pe’er, D. (2018). Recovering gene interactions from single-cell data using data diffusion. Cell, 174(3), 716-729.e27. https://doi.org/10.1016/j.cell.2018.05.061
Van Renterghem, P., Sottas, P. E., Saugy, M., & Van Eenoo, P. (2013). Statistical discrimination of steroid profiles in doping control with support vector machines. Analytica Chimica Acta, 768, 41–48. https://doi.org/10.1016/j.aca.2013.01.003
Van Renterghem, P., Van Eenoo, P., Geyer, H., Schänzer, W., & Delbeke, F. T. (2010). Reference ranges for urinary concentrations and ratios of endogenous steroids, which can be used as markers for steroid misuse, in a Caucasian population of athletes. Steroids, 75(2), 154–163. https://doi.org/10.1016/j.steroids.2009.11.008
WADA. The World Anti-Doping Code. (2020). The 2016 prohibited list international standard. Retrieved January, 2020, from https://www.wada-ama.org/sites/default/files/wada_2020_english_prohibited_list_0.pdf
Wang, G., Karanikolou, A., Verdouka, I., Friedmann, T., & Pitsiladis, Y. (2017). Next generation “omics” approaches in the “fight” against blood doping. Medicine and Sport Science, 62, 119–128. https://doi.org/10.1159/000470919
Wax, B., Kavazis, A. N., Brown, S. P., & Hilton, L. (2013). Effects of supplemental GAKIC ingestion on resistance training performance in trained men. Research Quarterly for Exercise and Sport, 84(2), 245–251. https://doi.org/10.1080/02701367.2013.784845
Younes, A. K., & Younes, N. K. (2017). Recovery of steroid induced adrenal insufficiency. Translational Pediatrics, 6(4), 269–273. https://doi.org/10.21037/tp.2017.10.01
Zheng, X., Qi, Y., Bi, L., Shi, W., Zhang, Y., Zhao, D., Hu, S., Li, M., & Li, Q. (2020). Effects of exercise on blood glucose and glycemic variability in type 2 diabetic patients with dawn phenomenon. Biomedical Research International, 2020, 6408724. https://doi.org/10.1155/2020/6408724
Ziegenfuss, T., Landis, J., & Hofheins, J. (2008). Acute supplementation with alpha-glycerylphosphorylcholine augments growth hormone response to, and peak force production during, resistance exercise. Journal of International Society Sports Nutrition, 5(Suppl 1), 15. https://doi.org/10.1186/1550-2783-5-S1-P15
Zorzoli, M., & Rossi, F. (2010). Implementation of the biological passport: The experience of the International Cycling Union. Drug Testing and Analysis, 2(11–12), 542–547. https://doi.org/10.1002/dta.173
Zorzoli, M., & Rossi, F. (2012). Case studies on ESA-doping as revealed by the biological passport. Drug Testing and Analysis, 4(11), 854–858. https://doi.org/10.1002/dta.1340
Zuber, V., & Strimmer, K. (2009). Gene ranking and biomarker discovery under correlation. Bioinformatics, 25(20), 2700–2707. https://doi.org/10.1093/bioinformatics/btp460
Acknowledgements
Authors thank sportsmen enrolled in the cohort of the French Federation of Cycling for having accepted to be anonymously involved in this exploratory phenotyping study. The French Federation of Cycling is acknowledged for his involvement in the study and providing samples. This study was supported by the French Agency for Doping Control (AFLD, contract Inserm n° R09223DD) and the World Anti-Doping Agency (WADA, contract n° 006D1442 – Inserm n° R07157DD). B Labrador was supported by AFLD and WADA and FX Lejeune by the French Agency of Research.
Author information
Authors and Affiliations
Contributions
AP, MG, JCT and YLB supervised this work. JCT, YLB, MR, MG and AP contributed to design the experiment. AM and MG contributed to sample handling and collection and sample biobanking. MG achieved endocrine phenotyping and curation. CC and JM performed metabolomic analyses. FXL, BL and AP performed statistical analyses. CC did an expert-based assignment of putative biomarkers. AP performed the data interpretation and wrote the manuscript. JCT, YLB, MG, MR, CC, FXL and BL revised the manuscript. All authors have read and approved the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to declare.
Ethical approval
The samples concerning metabolomic research were carried out during the mandatory medical and biological monitoring of the French Federation of Cycling (FFC) according to French legislation (article L 3621 of the French Public Health Code concerning protection of the health of sportsmen and women). The aliquots of blood samples reserved for this project were anonymized with a specific consent signed by those who gave their consent (WADA research grant and project submitted by WADA to an independent ethic review, reference number 06D14YL).
Informed consent
Informed consent was obtained from all participants included in the study.
Additional information
This paper is dedicated to the memory of Dr Armand Mégret who died in September 2019. He was pioneering at the very end of nineties in systematic serum biobanking to help to fight doping practices in sport, particularly in cycling.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Paris, A., Labrador, B., Lejeune, FX. et al. Metabolomic signatures in elite cyclists: differential characterization of a seeming normal endocrine status regarding three serum hormones. Metabolomics 17, 67 (2021). https://doi.org/10.1007/s11306-021-01812-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11306-021-01812-4